NET Clinical Trials in New York, New York

17 recruitingNew York, New York

Showing 117 of 17 trials

Recruiting
Phase 3

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals240 enrolled65 locationsNCT06784752
Recruiting
Phase 2Phase 3

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Symptomatic Genetic Dilated Cardiomyopathy
Kardigan, Inc.332 enrolled33 locationsNCT07210723
Recruiting

Pancreatic Cancer Early Detection Consortium

Pancreatic Ductal AdenocarcinomaPancreas CancerGenetic Predisposition+1 more
Arbor Research Collaborative for Health20,000 enrolled60 locationsNCT04970056
Recruiting
Phase 2Phase 3

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumor (pNET)Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis440 enrolled80 locationsNCT06943755
Recruiting
Not Applicable

rTMS for Postoperative Brain Tumor Patients

Quality of LifeBrain TumorsTranscranial Magnetic Stimulation+1 more
Brian J.Gill6 enrolled1 locationNCT07530536
Recruiting

Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

Genetic Disease
National Human Genome Research Institute (NHGRI)20,000 enrolled33 locationsNCT02450851
Recruiting
Phase 3

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563
Recruiting
Not Applicable

Universal Genetic Testing for Cancer Risk Reduction

Genetic Testing
NYU Langone Health600 enrolled1 locationNCT06926816
Recruiting
Phase 3

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Hypothalamic ObesityMultiple Pituitary Hormone Deficiency Genetic FormSepto-Optic Dysplasia+3 more
Rhythm Pharmaceuticals, Inc.39 enrolled11 locationsNCT06760546
Recruiting

Pancreas Registry and High Risk Registry

Pancreas CancerPancreatitisChronic Pancreatitis+3 more
Icahn School of Medicine at Mount Sinai1,368 enrolled2 locationsNCT02775461
Recruiting

Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations

Genetic TestingBRCA1/2
Memorial Sloan Kettering Cancer Center400 enrolled7 locationsNCT03396341
Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Mitochondrial DiseasesMitochondrial DisordersMitochondrial Genetic Disorders+2 more
Columbia University1,000 enrolled17 locationsNCT01694940
Recruiting

STXBP1 and SYNGAP1 Related Disorders Natural History Study

Genetic DiseaseSYNGAP1-Related Intellectual DisabilitySTXBP1 Encephalopathy With Epilepsy
Children's Hospital of Philadelphia600 enrolled5 locationsNCT06555965
Recruiting
Not Applicable

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Breast CancerPancreatic CancerOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center445 enrolled4 locationsNCT04751435
Recruiting
Not Applicable

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Aortic AneurysmAortic DissectionIntramural Hematoma+1 more
Endospan Ltd.110 enrolled32 locationsNCT04471909
Recruiting
Not Applicable

Genomic Uniformed-Screening Against Rare Disease In All Newborns

Early Onset Genetic Conditions With Near Complete Penetrance
Columbia University100,000 enrolled1 locationNCT05990179
Recruiting

InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort

Acute Lymphoblastic LeukemiaGenetic PredispositionNutrition Aspect of Cancer+1 more
Columbia University4,900 enrolled8 locationsNCT05929976